Sign in

CIK 0001585608

  • Non-accelerated filer
  • Smaller reporting company

Jaguar Health, Inc.

Sign in to watch
Ticker
JAGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 415-371-8300
Business address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
Former names
Jaguar Animal Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-10-08 Lizak Carol R. Chief Financial Officer Grant or award · Stock option (right to buy) +34,240 34,240
2024-10-08 Chaturvedi Pravin R Chief Scientific Officer Grant or award +4,922 4,957
2024-10-08 Chaturvedi Pravin R Chief Scientific Officer Grant or award · Stock option (right to buy) +39,376 39,376
2024-10-08 Wolin Jonathan S. See Remarks Grant or award +4,922 4,955
2024-10-08 Wolin Jonathan S. See Remarks Grant or award · Stock option (right to buy) +39,376 39,376
2024-10-08 CONTE LISA A See Remarks Grant or award +16,503 16,624
2024-10-08 CONTE LISA A See Remarks Grant or award · Stock option (right to buy) +132,020 132,020
2024-10-08 MICEK JOHN Director Grant or award · Stock option (right to buy) +26,500 26,500
2024-10-08 BOCHNOWSKI JAMES J Director Grant or award · Stock option (right to buy) +23,200 23,200
2024-10-08 Jayasuriya Anula Director Grant or award · Stock option (right to buy) +21,000 21,000
2024-10-08 King Steven R. See Remarks Grant or award +4,922 4,951
2024-10-08 King Steven R. See Remarks Grant or award · Stock option (right to buy) +39,376 39,376
2024-10-08 Siegel Jonathan B. Director Grant or award · Stock option (right to buy) +26,500 26,500
2024-05-17 Chaturvedi Pravin R Chief Scientific Officer Option exercise +871 2,141
2024-05-17 Chaturvedi Pravin R Chief Scientific Officer Option exercise · Restricted stock units −871 871
2024-05-17 Wolin Jonathan S. Chief of Staff, CCO & GC Option exercise +871 2,012
2024-05-17 Wolin Jonathan S. Chief of Staff, CCO & GC Option exercise · Restricted stock units −871 871
2024-05-17 Lizak Carol R. Chief Financial Officer Option exercise +431 1,042
2024-05-17 Lizak Carol R. Chief Financial Officer Option exercise · Restricted stock units −431 431
2024-05-17 King Steven R. See Remarks Option exercise +612 1,756

Page 4 of 10 · 185 trades